CARLSBAD, CA -- (Marketwire) -- 07/18/12 -- International Stem Cell Corporation (OTCBB: ISCO),www.internationalstemcell.com, a California-based biotechnology company focused on therapeutic and research products, announced today that Co-Chairman of the Board and Chief Executive Officer Andrey Semechkin PhD has published a letter to shareholders.
The letter addresses recent corporate governance and operational changes, as well as providing an update on ISCO's Research and Development accomplishments, challenges and 2012 - 2013 major milestones and information on both the Lifeline Skin Care's and Lifeline Cell Technology's recent activities.
The full text of the letter can be found at
No comments:
Post a Comment